Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
AstraZeneca Pharma India Ltd.
BSE
Price on BSE
24 Apr,15:28 LIVE
8,480.00
+30.60
(+0.36%)
© 2026 Rediff.com
Volume :
411.00
Prev Close :
8,449.40
Day's H/L (Rs.) :
8,588.50 - 8,331.10
52wk H/L (Rs.) :
10,653.05 - 7,630.00
Mkt Cap (Rs. Cr) :
21,200.00
NSE
Price on NSE
24 Apr,15:59 LIVE
8,500.00
+43.50
(+0.51%)
© 2026 Rediff.com
Volume :
6,543.00
Prev Close :
8,456.50
Day's H/L (Rs.) :
8,594.00 - 8,325.50
52wk H/L (Rs.) :
10,691.00 - 7,551.50
Mkt Cap (Rs. Cr) :
0.00
View more
Market News
Rare-Disease, Cancer Drugs Get Cheaper
Rediff.com
03 Feb 2026
Report Card - AstraZeneca Pharma India Ltd.
PE Ratios
182.70
EPS (Rs.)
46.30
Sales (Rs. Cr)
611.57
Face Value (Rs.)
2
Net Profit Margin(%)
6.74
Last Bonus
1:1
Last Dividend(%)
1600
Return on Average Equity
15.02
News for AstraZeneca Pharma India Ltd.
Aurobindo Pharma Gets USFDA Nod for Dapagliflozin
Aurobindo Pharma receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type 2 diabetes.
Apr 07, 2026 19:37
Alembic Pharma Gets USFDA Nod for Dapagliflozin
Alembic Pharmaceuticals receives USFDA approval for generic dapagliflozin tablets (5mg & 10mg) to control blood sugar in type-2 diabetes.
Apr 07, 2026 12:51
AstraZeneca Imfinzi Approved in India for Endometrial Cancer
AstraZeneca Pharma India gets approval to market Imfinzi (Durvalumab) for advanced endometrial cancer treatment in India.
Feb 10, 2026 14:05
AstraZeneca Durvalumab Approved for Gastric Cancer
CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.
Feb 04, 2026 14:19
Starmer Secures UK-China Export & Investment Deals
PM Starmer concludes China visit with multi-billion pound export and investment deals, boosting UK-China relations and trade.
Jan 31, 2026 18:27
More News for AstraZeneca Pharma India Ltd. »
News for Pharmaceuticals and health care
Gold & Silver Prices Drop on Stronger US Dollar
Gold and silver prices fall for the 3rd day due to a strengthening US dollar and global uncertainty. Get the latest market analysis.
Apr 24, 2026 18:35
India Wheat Output 2025-26: Impact of Weather
India's wheat production for 2025-26 is projected at 110-120 mn tons due to weather damage. Procurement target raised to 34.5 mn tons.
Apr 24, 2026 18:20
Sebi Allows Net Settlement for FPIs
Sebi permits net settlement of funds for FPIs in cash market trades, enhancing efficiency and reducing funding costs. Implementation by Dec 31, 2026.
Apr 24, 2026 18:08
Today''s Gold & Silver Rates in Bengaluru
Check the closing bullion rates in Bengaluru for today. Find the latest gold prices (22Kt & 24Kt) and silver rates per KG.
Apr 24, 2026 17:54
Market Slump: Investors Lose Rs 7.17 Lakh Cr
Investors' wealth plunges by Rs 7.17 lakh crore in three days amid market slump. West Asia tensions, crude oil prices, and IT sector woes weigh.
Apr 24, 2026 17:46
More News »
Top News
Gold & Silver Prices Drop on Stronger US Dollar
Gold and silver prices fall for the 3rd day due to a strengthening US dollar and global uncertainty. Get the latest market analysis.
Apr 24, 2026 18:35
India Wheat Output 2025-26: Impact of Weather
India's wheat production for 2025-26 is projected at 110-120 mn tons due to weather damage. Procurement target raised to 34.5 mn tons.
Apr 24, 2026 18:20
Mining Auction: Rs 5,000 Cr Incentive for States
Govt announces Rs 5,000 crore incentive for states to expedite mining blocks'' auction & operationalisation. Scheme details inside.
Apr 24, 2026 18:20
SBI General Insurance Profit Up 9% to Rs 553 Cr
SBI General Insurance reports 8.6% net profit increase to Rs 553 crore in FY26. Gross direct premium grows 14.5%. Solvency ratio strong at 1.90.
Apr 24, 2026 18:11
PropShare Celestia Units Debut Lower on BSE
PropShare Celestia units ended over 1% lower on their trading debut on BSE. IPO received 1.33x subscription. Details here.
Apr 24, 2026 18:11
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist